Pedram Gerami Selected Research

Nevus (Nevi)

8/2022	PRAME Expression Correlates With Genomic Aberration and Malignant Diagnosis of Spitzoid Melanocytic Neoplasms.
1/2022	Benign and Intermediate-grade Melanocytic Tumors With BRAF Mutations and Spitzoid Morphology: A Subset of Melanocytic Neoplasms Distinct From Melanoma.
12/2020	Melanocytic Neoplasms With MAP2K1 in Frame Deletions and Spitz Morphology.
12/2020	Molecular analysis of atypical deep penetrating nevus progressing to melanoma.
2/2018	Genomic Assessment of Blitz Nevi Suggests Classification as a Subset of Blue Nevus Rather Than Spitz Nevus: Clinical, Histopathologic, and Molecular Analysis of 18 Cases.
1/2018	Genomic Fusions in Pigmented Spindle Cell Nevus of Reed.
8/2016	Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi.
8/2014	Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
4/2010	Polyploidy in spitz nevi: a not uncommon karyotypic abnormality identifiable by fluorescence in situ hybridization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedram Gerami Research Topics

Disease

27	Melanoma (Melanoma, Malignant) 08/2022 - 09/2008
25	Neoplasms (Cancer) 12/2022 - 08/2009
9	Nevus (Nevi) 08/2022 - 04/2010
4	Mycosis Fungoides 03/2019 - 02/2008
3	Inflammation (Inflammations) 09/2010 - 04/2006
3	Skin Diseases (Skin Disease) 01/2010 - 01/2006
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2013
2	Exanthema (Rash) 11/2010 - 09/2010
2	Lymphoma (Lymphomas) 12/2009 - 08/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2019
1	Anemia 01/2018
1	Infections 07/2017
1	Warts (Wart) 07/2017
1	Lymphatic Metastasis 01/2017
1	Alopecia (Baldness) 12/2016
1	Hyperplasia 03/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2015
1	Fibrosis (Cirrhosis) 05/2014
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 12/2012
1	Disease Progression 07/2012
1	Breast Neoplasms (Breast Cancer) 11/2010
1	Calcinosis 01/2010
1	Calcinosis Cutis 01/2010
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2009
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2009
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2006
1	Muscle Weakness 04/2006
1	Pyoderma Gangrenosum 01/2006
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 01/2006

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2011
6	Messenger RNA (mRNA)IBA 12/2021 - 08/2014
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2009
5	Cyclin D1IBA 01/2018 - 09/2008
4	Phosphotransferases (Kinase)IBA 11/2019 - 04/2017
3	AntigensIBA 08/2022 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2016 - 01/2006
2	Mitogen-Activated Protein KinasesIBA 12/2020 - 02/2012
2	Biological ProductsIBA 01/2020 - 06/2011
2	CytokinesIBA 03/2019 - 03/2015
2	ChromatinIBA 03/2017 - 02/2013
2	ParaffinIBA 01/2017 - 08/2009
2	Biomarkers (Surrogate Marker)IBA 08/2016 - 09/2010
2	Indicators and Reagents (Reagents)IBA 07/2012 - 09/2008
1	1- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA 12/2022
1	Protein Kinases (Protein Kinase)IBA 08/2022
1	Coloring Agents (Dyes)IBA 08/2022
1	NAD (NADH)IBA 12/2020
1	Melanins (Melanin)IBA 12/2020
1	CateninsIBA 12/2020
1	Aurora Kinase AIBA 07/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Voriconazole (Vfend)FDA LinkGeneric 01/2019
1	Transaminases (Aminotransferases)IBA 01/2018
1	Cimetidine (Biomet)FDA LinkGeneric 07/2017
1	Imiquimod (Aldara)FDA LinkGeneric 07/2017
1	Long Noncoding RNAIBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Triamcinolone (Aristocort)FDA Link 12/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2016
1	Transcription Factors (Transcription Factor)IBA 03/2015
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 03/2015
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 03/2015
1	CollagenIBA 05/2014
1	VemurafenibIBA 12/2012
1	Antineoplastic Agents (Antineoplastics)IBA 09/2010
1	Panitumumab (Vectibix)FDA Link 09/2010
1	Lapatinib (GW572016)FDA Link 09/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2010
1	Cetuximab (Erbitux)FDA Link 09/2010
1	ErbB Receptors (EGF Receptor)IBA 09/2010
1	Complement System Proteins (Complement)IBA 04/2010
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2010
1	Rituximab (Mabthera)FDA Link 01/2010
1	Methotrexate (Mexate)FDA LinkGeneric 01/2010
1	Alemtuzumab (Campath)FDA Link 12/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2009
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2009
1	G(M3) GangliosideIBA 11/2009
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2009
1	Bexarotene (LGD1069)FDA Link 02/2008
1	Antinuclear AntibodiesIBA 04/2006
1	AutoantibodiesIBA 04/2006
1	EnzymesIBA 04/2006

Therapy/Procedure

9	Therapeutics 09/2013 - 01/2006
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 09/2018
2	Radiotherapy 01/2019 - 11/2010
1	Molecular Targeted Therapy 11/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Cryosurgery 07/2017
1	Injections 12/2016